Sepsis biomarkers

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11110%2F15%3A10294781" target="_blank" >RIV/00216208:11110/15:10294781 - isvavai.cz</a>
Alternative codes found
RIV/00064190:_____/15:#0001148 RIV/00023884:_____/12:00006158
Result on the web
<a href="http://dx.doi.org/10.1016/j.cca.2014.11.012" target="_blank" >http://dx.doi.org/10.1016/j.cca.2014.11.012</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1016/j.cca.2014.11.012" target="_blank" >10.1016/j.cca.2014.11.012</a>

Result language
angličtina
Original language name
Sepsis biomarkers
Original language description
Sepsis is the most frequent cause of death in non-coronary intensive care units (ICUs). In the past 10 years, progress has been made in the early identification of septic patients and in their treatment and these improvements in support and therapy meanthat the mortality is gradually decreasing but it still remains unacceptably high. Leaving clinical diagnosis aside, the laboratory diagnostics represent a complex range of investigations that can place significant demands on the system given the speed of response required. There are hundreds of biomarkers which could be potentially used for diagnosis and prognosis in septic patients. The main attributes of successful markers would be high sensitivity, specificity, possibility of bed-side monitoring, and financial accessibility. Only a fraction is used in routine clinical practice because many lack sufficient sensitivity or specificity. The following review gives a short overview of the current epidemiology of sepsis, its pathogenesis a
Czech name
—
Czech description
—

Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FP - Other medical fields
OECD FORD branch
—

Publication year
2015
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Similar results(10)